Christina A. Rostad, MD

Associate Professor of Pediatrics
Emory University School of Medicine and Children's Healthcare of Atlanta
Atlanta, GA, United States

Disclosure(s): Janssen: Grant/Research Support; Meissa Vaccines: Grant/Research Support, International PCT Application No. PCT/US2016/058976, filed 12/28/2016 by Emory University; Merck: Grant/Research Support; Micron: Grant/Research Support; Moderna, Inc: Grant/Research Support; Pfizer, Inc.: Grant/Research Support; Sanofi: Grant/Research Support, Sanofi provided investigational product (nirsevimab) for the conduct of this study.

Presentation(s):

• Career Breakout Introductions

  Sunday, October 19, 2025
  10:00 AM - 10:15 AM US ET

• 225 - The Immunology and Safety of Maternal RSV Vaccination, Infant Nirsevimab Immunization, or Both Products- Interim Analysis of a Randomized Clinical Trial

  Monday, October 20, 2025
  3:27 PM - 3:39 PM US ET

• 244 - Challenging Vaccine Issues: Beyond the Guidelines

  Wednesday, October 22, 2025
  1:45 PM - 3:00 PM US ET